Description
Rifaximin is a nonsystemic antibiotic, meaning it targets the gastrointestinal tract specifically. It inhibits RNA polymerase, which results in the inhibition of bacterial protein synthesis and killing of the microorganisms. This action is what makes it a broad-spectrum antibiotic, active against various gram-positive and gram-negative bacteria, including anaerobic bacteria. When traveler’s diarrhea occurs, rifaximin is administered to inhibit the mobilization of bile acids from the liver, minimizing the growth of bacteria in the gastrointestinal tract known to cause this condition.
Ingredients
Rifaximin
Uses
Unveiling its multifaceted uses and transformative applications as follows:
- Treatment of intestinal infections caused by non-invasive strains of Escherichia coli and other gram-negative bacteria.
- Treatment of intestinal infections caused by Staphylococcus aureus or Enterococcus faecalis.
- Reduce the risk of recurrence of hepatic encephalopathy (HE) episodes in patients with advanced liver disease.
- Treatment of irritable bowel syndrome (IBS) in women with abdominal pain and diarrhea.
- May be given intravenously for travelers’ diarrhea.
- Treat diverticular disease.
- Giardiasis (intestinal parasite).
Reviews
There are no reviews yet.